Yasemin Altuner Torun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yasemin Altuner Torun has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ayse Betul Ergul
Department of Pediatrics, Kayseri Training and Research Hospital, Kayseri, Turkey
1 shared publication - Burcu Öksüz
Molecular Infection Laboratory, Genetic Diseases Diagnosis Center, İstinye University, Istanbul, Turkey
1 shared publication - Cigdem Karakukcu
Department of Medical Biochemistry, Erciyes University Faculty of Medicine, Kayseri, Türkiye
1 shared publication - Mehmet Sabanci
Istinye University School of Medicine, Istanbul, Turkey
1 shared publication - Mehmet Taşdemir
Department of Pediatric Nephrology, Faculty of Medicine, Istinye University, Istanbul 34475, Türkiye
1 shared publication - Murat Sütçü
Department of Pediatric Infectious Diseases, Faculty of Medicine, Istinye University, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 22 May 2024
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39 (10) , 2923-2925
Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant
A 13-year-old girl who had a kidney transplant four weeks prior presented with a 10-day history of fatigue, paleness, and headache. On physical examination, tachycardia and paleness were noted. Laboratory testing was notable for severe anemia and mild leukopenia and thrombocytopenia. Polymerase chain reaction (PCR) test for Epstein-Barr virus (EBV) and cytomegalovirus (CMV) were negative and for parvovirus B19 (PVB19) was positive. Despite lower immunosuppression and administration of intravenous immunoglobulin (IVIG) it persisted for 15 months, and frequent red blood cell transfusions were needed. PVB19 is a less common but significant complication. The patient's clinical course demonstrates the importance of this complication and the challenges in its management. A notable void exists in the literature regarding standardized treatment protocols for PVB19-induced recurrent anemia after kidney transplant. This case indicates the need for further research and consensus to guide effective clinical interventions in similar cases.
- 22 May 2024
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39 (10) , 2923-2925
Open AccessManaging recurrent parvovirus B19-associated anemia after a pediatric kidney transplant
A 13-year-old girl who had a kidney transplant four weeks prior presented with a 10-day history of fatigue, paleness, and headache. On physical examination, tachycardia and paleness were noted. Laboratory testing was notable for severe anemia and mild leukopenia and thrombocytopenia. Polymerase chain reaction (PCR) test for Epstein-Barr virus (EBV) and cytomegalovirus (CMV) were negative and for parvovirus B19 (PVB19) was positive. Despite lower immunosuppression and administration of intravenous immunoglobulin (IVIG) it persisted for 15 months, and frequent red blood cell transfusions were needed. PVB19 is a less common but significant complication. The patient's clinical course demonstrates the importance of this complication and the challenges in its management. A notable void exists in the literature regarding standardized treatment protocols for PVB19-induced recurrent anemia after kidney transplant. This case indicates the need for further research and consensus to guide effective clinical interventions in similar cases.
- 9 November 2016
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 30 (19) , 2297-2300
Reduction in serum paraoxonase level in newborns with hyperbilirubinemia as a marker of oxidative stress
Objective: Indirect bilirubin exerts an antioxidant effect when increased mildly. This study aimed to investigate whether increased bilirubin levels lead to an oxidant effect in newborns with hyperbilirubinemia requiring phototherapy. Patients and methods: The study included 30 term newborn infants aged 0–7 days with indirect hyperbilirubinemia requiring phototherapy and no comorbid disease as the study group. In addition, 30 term healthy newborn infants aged 0–7 days without indirect hyperbilirubinemia were employed as a control group. Serum triglyceride, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), serum paraoxonase (PON) levels and malondialdehyde (MDA) levels were compared between the groups. Results: Serum MDA, total bilirubin, and LDL and HDL levels were significantly higher and the serum PON level was significantly lower, in the study group compared with the controls (p < 0.05). Conclusion: In newborns with hyperbilirubinemia requiring phototherapy, an increased bilirubin level causes oxidative stress by decreasing the level of serum PON and increasing the level of MDA.
- 9 November 2016
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 30 (19) , 2297-2300
Reduction in serum paraoxonase level in newborns with hyperbilirubinemia as a marker of oxidative stress
Objective: Indirect bilirubin exerts an antioxidant effect when increased mildly. This study aimed to investigate whether increased bilirubin levels lead to an oxidant effect in newborns with hyperbilirubinemia requiring phototherapy. Patients and methods: The study included 30 term newborn infants aged 0–7 days with indirect hyperbilirubinemia requiring phototherapy and no comorbid disease as the study group. In addition, 30 term healthy newborn infants aged 0–7 days without indirect hyperbilirubinemia were employed as a control group. Serum triglyceride, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), serum paraoxonase (PON) levels and malondialdehyde (MDA) levels were compared between the groups. Results: Serum MDA, total bilirubin, and LDL and HDL levels were significantly higher and the serum PON level was significantly lower, in the study group compared with the controls (p < 0.05). Conclusion: In newborns with hyperbilirubinemia requiring phototherapy, an increased bilirubin level causes oxidative stress by decreasing the level of serum PON and increasing the level of MDA.